You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FT-1101

Showing 1 - 25 of 144
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)

Completed
  • Acute Myeloid Leukemia
  • +3 more
  • Los Angeles, California
  • +7 more
Jun 25, 2019

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Completed
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Taichung City, Taiwan
  • +3 more
Nov 17, 2022

Granuloma Annulare Trial in New Haven (AC-1101)

Recruiting
  • Granuloma Annulare
  • New Haven, Connecticut
    Yale Center for Clinical Investigation
Nov 2, 2022

Altitude Hypoxia Trial (Hypoxic breathing conditions)

Not yet recruiting
  • Altitude Hypoxia
  • Hypoxic breathing conditions
  • (no location specified)
May 10, 2023

Interlaminar Epidural Steroid Injections?

Recruiting
  • Cervical Disc Herniation
  • +2 more
  • Interlaminar Epidural Steroid Injection
  • Istanbul, Pendik, Turkey
    Marmara University Pendik Training and Research Hospital
Nov 25, 2022

Diabetic Macular Edema Trial in Tianjin (FT-003)

Recruiting
  • Diabetic Macular Edema
  • FT-003
  • Tianjin, Tianjin,China, China
    Tianjin Medical University Eye Hospital
Jun 14, 2023

Neovascular Age-related Macular Degeneration Trial (FT-003)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • FT-003
  • (no location specified)
Nov 21, 2022

Fetal Monitoring Trial in Genk (Bloomlife Lovelace FT)

Recruiting
  • Fetal Monitoring
  • Bloomlife Lovelace FT
  • Genk, Limburg, Belgium
    Ziekenhuis Oost-Limburg
Dec 13, 2022

Type 1 Diabetes Trial in Houston (Family Teamwork-Peer Delivery)

Completed
  • Type 1 Diabetes
  • Family Teamwork-Peer Delivery
  • Houston, Texas
    Texas Children's Hospital
Jul 22, 2022

Biallelic RPE65 Mutation-associated Retinal Dystrophy Trial in Beijing (FT-001 Low Dose, FT-001 Mid Dose, FT-001 High Dose)

Recruiting
  • Biallelic RPE65 Mutation-associated Retinal Dystrophy
  • FT-001 Low Dose
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 11, 2023

Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

Withdrawn
  • Myelodysplastic Syndrome
  • SyB C-1101 and Azacytidine
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • FT-2102 (olutasidenib)
  • +2 more
  • Los Angeles, California
  • +59 more
Mar 2, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (FT-7051)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Scottsdale, Arizona
  • +7 more
May 12, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +8 more
Nov 14, 2022

Urinary Tract Infections Trial in Doorn, Utrecht (Fosfomycin, Nitrofurantoin)

Terminated
  • Urinary Tract Infections
  • Doorn, Utrecht, Netherlands
  • +3 more
Feb 27, 2022

PRO for Fighting FT in Ovarian Cancer

Not yet recruiting
  • Ovarian Cancer
  • Questionnaires
  • Naples, Italy
    Nation Cancer Institute of Naples, Division of Medical Oncology
Sep 13, 2023

Advanced Refractory Solid Tumors Trial in Kaohsiung, Tainan (T-1101 (Tosylate))

Recruiting
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Kaohsiung, Taiwan
  • +1 more
Oct 31, 2021

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB L-1101
  • Nagoya, Aichi, Japan
  • +2 more
Nov 14, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Gut Microbiota of Preterm Infants and Full-term Infants at Early

Recruiting
  • Preterm Infant
  • Gut Microbiome
    • Shanghai, China
      Department of NICU, XinHua Hospital Affiliated to Shanghai Jiao
    May 10, 2022

    Mental Disorders Trial in Stockholm (Braining, Treatment as usual)

    Not yet recruiting
    • Mental Disorders
    • Braining
    • Treatment as usual
    • Stockholm, Sweden
    • +3 more
    Aug 21, 2023